IP Library Granted Patent US 11,369,642
Granted Patent B2
US 11,369,642 · App. 16/539,401 · Granted Jun 28, 2022

Methods for lowering blood glucose

Inventor: Jean Xu (Skillman, NJ)
Assignee: Janssen Biotech, Inc.
A61K35/39
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,369,642
App. No.
16/539,401
Granted
Jun 28, 2022
Kind
B2
Abstract

The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.

Claims (4)

1. A method for lowering blood glucose levels in a mammal, comprising transplanting a population of pancreatic endocrine precursor cells expressing insulin, NKX6.1 and PDX1, but not expressing CDX2, into the liver, natural pancreas, renal subcapsular space, omentum, peritoneum, subserosal space, intestine, or a subcutaneous pocket of the mammal, wherein the pancreatic endocrine precursor cells express insulin, lower the blood glucose levels in the mammal, and are protected from host immune response when transplanted.

2. The method of claim 1 , wherein the pancreatic endocrine precursor cells are in a biocompatible degradable polymeric support, a porous non-degradable device or encapsulated when transplanted.

3. The method of claim 2 , wherein pancreatic endocrine precursor cells are encapsulated.

4. The method of claim 3 , wherein the encapsulated cells are transplanted subcutaneously.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2019
From: XU, JEAN
To: JANSSEN BIOTECH, INC.
Reel/Frame 050702/0325 →
Continuity (4)
Continuation 16134831 · Sep 18, 2018
Continuation 12838998 · Jul 19, 2010
Provisional Application 61226923 · Jul 20, 2009
Related Publication 20200030382A1 · Jan 30, 2020